RTOG 0529: A Phase 2 Evaluation of Dose-Painted Intensity Modulated Radiation Therapy in Combination With 5-Fluorouracil and Mitomycin-C for the Reduction of Acute Morbidity in Carcinoma of the Anal Canal
Top Cited Papers
Open Access
- 1 May 2013
- journal article
- research article
- Published by Elsevier BV in International Journal of Radiation Oncology*Biology*Physics
- Vol. 86 (1), 27-33
- https://doi.org/10.1016/j.ijrobp.2012.09.023
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Dose-Painted Intensity-Modulated Radiation Therapy for Anal Cancer: A Multi-Institutional Report of Acute Toxicity and Response to TherapyInternational Journal of Radiation Oncology*Biology*Physics, 2012
- Elective Clinical Target Volumes for Conformal Therapy in Anorectal Cancer: A Radiation Therapy Oncology Group Consensus Panel Contouring AtlasInternational Journal of Radiation Oncology*Biology*Physics, 2009
- Fluorouracil, Mitomycin, and Radiotherapy vs Fluorouracil, Cisplatin, and Radiotherapy for Carcinoma of the Anal CanalJama-Journal Of The American Medical Association, 2008
- Association Between Bone Marrow Dosimetric Parameters and Acute Hematologic Toxicity in Anal Cancer Patients Treated With Concurrent Chemotherapy and Intensity-Modulated RadiotherapyInternational Journal of Radiation Oncology*Biology*Physics, 2008
- Recurrence in Region of Spared Parotid Gland After Definitive Intensity-Modulated Radiotherapy for Head and Neck CancerInternational Journal of Radiation Oncology*Biology*Physics, 2008
- Concurrent Chemotherapy and Intensity-Modulated Radiation Therapy for Anal Canal Cancer Patients: A Multicenter ExperienceJournal of Clinical Oncology, 2007
- Intensity-modulated radiation therapy (IMRT) in the treatment of anal cancer: Toxicity and clinical outcomeInternational Journal of Radiation Oncology*Biology*Physics, 2005
- Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycinThe Lancet, 1996
- Optimal two-stage designs for phase II clinical trialsControlled Clinical Trials, 1989
- Combined therapy for cancer of the anal canalDiseases of the Colon & Rectum, 1974